At BioMarin, we realize the importance of extending our support of scientific advancement beyond the research we conduct and the medicines we provide. We support activities that make useful information and resources available to the broader medical and scientific communities to help advance science, increase understanding of certain diseases and enhance patient care.
Learn about how we support external scientific research below. For information about additional funding opportunities, visit our Corporate Giving page.
Independent Medical Education funding supports accredited or non-accredited medical education activities for healthcare providers where content is not controlled or influenced by BioMarin. Independent Medical Education includes both continuing medical education (CME) and non-CME programs, and both may originate from similar types of organizations (e.g., hospitals, professional societies, or third-party, medical-education providers).
In alignment with our commitment to scientific innovation in areas of unmet medical need, we may provide product and funding support for external research in rare diseases and genetic disorders.
Our medical science staff located across the globe are available to guide you through each step in the application process. If you have a concept you would like to submit, please reach out to your Medical Science Liaison (MSL) or Area Medical Director. If you don’t yet have a medical staff contact or have a general inquiry, please email us at: externalresearch@bmrn.com.
BioMarin can provide qualified scientific researchers access to de-identified patient-level data collected in clinical trials to improve patient care and help advance medical science. Read our Data Sharing Request Policy.
Publication Data Requests are reviewed on a quarterly basis.
Our BioMarin Skeletal Dysplasia (BISK) Research Awards program seeks to grow the scientific understanding of skeletal dysplasia by supporting healthcare professionals such as physicians, allied healthcare practitioners and scientists leading research in innovative and understudied areas. Eligible applicants include any healthcare professionals such as physicians, allied health practitioners and research scientists working within the skeletal dysplasia space in the United States.
Six awards are available for the 2026 cycle, each worth up to $25,000 per recipient to support one year of research. Letters of intent are due by Sept. 30, 2026.
We do not provide support to organizations that, in their constitution or practice, discriminate against a person or group on the basis of age, political affiliation, race, national origin, ethnicity, gender, gender identity, disability, sexual orientation, HIV status or religious belief.